MARKSANS PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 166.8 INR | -1.36% |
|
+4.77% | +3.57% |
| 04-18 | Marksans Pharma's Goa Facility Gets Five Inspectional Observations from US FDA | MT |
| 02-14 | Transcript : Marksans Pharma Limited, Q3 2024 Earnings Call, Feb 14, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MARKSANS PHARMA LIMITED | Other Pharmaceuticals | -1.36% | +4.77% | +3.57% | +122.47% | +676.05% | 908M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- MARKSANS Stock
- Charts Marksans Pharma Limited
- Comparison Chart
